Stem cell mitochondria during aging

Seminars in Cell and Developmental Biology

Volumn 52, Issue , 2016, Pages 110-118

  Min Wen, Jason Chua ^a   Jun Hao, Elwin Tan ^a   Shyh Chang, Ng ^a  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Aging; Degeneration; Mitochondria; MtDNA; Regeneration; Stem cells

Indexed keywords

ADENYLATE KINASE; INSULIN; LIN28 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; RAS PROTEIN; RNA BINDING PROTEIN; TCL1 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; DIET RESTRICTION; HISTONE ACETYLATION; HOMEOSTASIS; HUMAN; LONGEVITY; METABOLIC DISORDER; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL GENOME; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL MITOCHONDRIA; STEM CELL SELF-RENEWAL; TISSUE DEGENERATION; TISSUE REGENERATION; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

ANIMALS; CELL AGING; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 84958128060     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2016.02.005     Document Type: Review

References (152)

1. Wallace D.C. The epigenome and the mitochondrion: bioenergetics and the environment. Genes Dev. 2010, 24:1571-1573.
2. Shyh-Chang N., Daley G.Q., Cantley L.C. Stem cell metabolism in tissue development and aging. Development 2013, 140:2535-2547.
3. Shyh-Chang N., Daley G.Q. Metabolic switches linked to pluripotency and embryonic stem cell differentiation. Cell Metab. 2015, 21:349-350.
4. Shyh-Chang N., Locasale J.W., Lyssiotis C.A., Zheng Y., Teo R.Y., Ratanasirintrawoot S., Zhang J., Onder T., Unternaehrer J.J., Zhu H., Asara J.M., Daley G.Q., Cantley L.C. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013, 339:222-226.
5. Shyh-Chang N., Zheng Y., Locasale J.W., Cantley L.C. Human pluripotent stem cells decouple respiration from energy production. EMBO J. 2011, 30:4851-4852.
6. Rossi D.J., Jamieson C.H., Weissman I.L. Stems cells and the pathways to aging and cancer. Cell 2008, 132:681-696.
7. Sahin E., Depinho R.A. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 2010, 464:520-528.
8. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
9. Jun-Hao E.T., Gupta R.R., Shyh-Chang N. Lin28 and let-7 in the metabolic physiology of aging. Trends Endocrinol. Metab. 2016, pii: S1043-2760(15) 00251-9. 10.1016/j.tem.2015.12.006.
10. Zhu H., Shyh-Chang N., Segrè A.V., Shinoda G., Shah S.P., Einhorn W.S., Takeuchi A., Engreitz J.M., Hagan J.P., Kharas M.G., Urbach A., Thornton J.E., Triboulet R., Gregory R.I., DIAGRAM Consortium, MAGIC Investigators, Altshuler D., Daley G.Q. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011, 147:81-94.
11. Shyh-Chang N., Zhu H., Yvanka de Soysa T., Shinoda G., Seligson M.T., Tsanov K.M., Nguyen L., Asara J.M., Cantley L.C., Daley G.Q. Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell 2013, 155:778-792.
12. Benhamed M., Herbig U., Ye T., Dejean A., Bischof O. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat. Cell Biol. 2012, 14:266-275.
13. Drummond M.J., McCarthy J.J., Sinha M., Spratt H.M., Volpi E., Esser K.A., Rasmussen B.B. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol. Genomics 2011, 43:595-603.
14. Toledano H., D'Alterio C., Czech B., Levine E., Jones D.L. The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche. Nature 2012, 485:605-610.
15. Yuan J., Nguyen C.K., Liu X., Kanellopoulou C., Muljo S.A. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 2012, 335:1195-1200.
16. Copley M.R., Babovic S., Benz C., Knapp D.J., Beer P.A., Kent D.G., Wohrer S., Treloar D.Q., Day C., Rowe K., Mader H., Kuchenbauer F., Humphries R.K., Eaves C.J. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 2013, 15:916-925.
17. Urbach A., Yermalovich A., Zhang J., Spina C.S., Zhu H., Perez-Atayde A.R., Shukrun R., Charlton J., Sebire N., Mifsud W., Dekel B., Pritchard-Jones K., Daley G.Q. Lin28 sustains early renal progenitors and induces Wilms tumor. Genes Dev. 2014, 28:971-982.
18. Tolonen, et al. Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacol. Res. Perspect. 2014, 2(4):e00056.
19. Zhang, et al. Lin28a protects against cardiac ischaemia/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway. J. Cell. Mol. Med. 2015, 19(6):1174-1182.
20. Zhang, et al. Lin28a protects against hypoxia/reoxygenation induced cardiomyocytes apoptosis by alleviating mitochondrial dysfunction under high glucose/high fat conditions. PLoS One 2014, 9(10):e110580.
21. Wu L., et al. Precise let-7 expression levels balance organ regeneration against tumor suppression. Elife 2015, 4. 10.7554/eLife.09431.
22. Aguirre, et al. In vivo activation of a conserved microRNA program induces mammalian heart regeneration. Cell Stem Cell 2014, 15(5):589-604.
23. Porrello E.R., Mahmoud A.I., Simpson E., Hill J.A., Richardson J.A., Olson E.N., Sadek H.A. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331:1078-1080.
24. Wang G., Chen H.W., Oktay Y., Zhang J., Allen E.L., Smith G.M., Fan K.C., Hong J.S., French S.W., McCaffery J.M., Lightowlers R.N., Morse H.C., Koehler C.M., Teitell M.A. PNPASE regulates RNA import into mitochondria. Cell 2010, 142:456-467.
25. Khaw S.L., Min-Wen C., Koh C.G., Lim B., Shyh-Chang N. Oocyte factors suppress mitochondrial polynucleotide phosphorylase to remodel the metabolome and enhance reprogramming. Cell Rep. 2015, 12:1080-1088.
26. French S.W., Dawson D.W., Chen H.W., Rainey R.N., Sievers S.A., Balatoni C.E., Wong L., Troke J.J., Nguyen M.T., Koehler C.M., Teitell M.A. The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activity. Cancer Lett. 2007, 248:198-210.
27. von Ameln S., Wang G., Boulouiz R., Rutherford M.A., Smith G.M., Li Y., Pogoda H.M., Nürnberg G., Stiller B., Volk A.E., et al. A mutation in PNPT1, encoding mitochondrial-RNA-import protein PNPase, causes hereditary hearing loss. Am. J. Hum. Genet. 2012, 91(5):919-927.
28. Vedrenne V., Gowher A., De Lonlay P., Nitschke P., Serre V., Boddaert N., Altuzarra C., Mager-Heckel A.M., Chretien F., Entelis N., Munnich A., Tarassov I., Rötig A. Mutation in PNPT1, which encodes a polyribonucleotide nucleotidyltransferase, impairs RNA import into mitochondria and causes respiratory-chain deficiency. Am. J. Hum. Genet. 2012, 91:912-918.
29. old-35, in the context of terminal differentiation and cellular senescence. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16636-16641.
30. old-35, a type I interferon inducible early response gene. Gene 2003, 316:143-156.
31. old-35) in human melanoma cells. J. Biol. Chem. 2003, 278:24542-24551.
32. Fulco M., Schiltz R.L., Iezzi S., King M.T., Zhao P., Kashiwaya Y., Hoffman E., Veech R.L., Sartorelli V. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell. 2003, 12:51-62.
33. +-dependent SIRT deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 2015, 16:171-183.
34. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
35. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
36. Gerhart-Hines Z., Rodgers J.T., Bare O., Lerin C., Kim S.H., Mostoslavsky R., Alt F.W., Wu Z., Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 2007, 26:1913-1923.
37. Machida S., Booth F.W. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp. Gerontol. 2004, 39:1521-1525.
38. Wenz T., Rossi S.G., Rotundo R.L., Spiegelman B.M., Moraes C.T. Increased muscle PGC1a expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20405-20410.
39. Liang H., Balas B., Tantiwong P., Dube J., Goodpaster B.H., O'Doherty R.M., DeFronzo R.A., Richardson A., Musi N., Ward W.F. Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E945-54.
40. Bonen A. PGC-1alpha-induced improvements in skeletal muscle metabolism and insulin sensitivity. Appl. Physiol. Nutr. Metab. 2009, 34:307-314.
41. Hochmuth C.E., Biteau B., Bohmann D., Jasper H. Redox regulation by Keap1 and Nrf2 controls intestinal stem cell proliferation in Drosophila. Cell Stem Cell 2011, 8:188-199.
42. Rera M., Bahadorani S., Cho J., Koehler C.L., Ulgherait M., Hur J.H., Ansari W.S., Lo T., Jones D.L., Walker D.W. Modulation of longevity and tissue homeostasis by the Drosophila PGC-1 homolog. Cell Metab. 2011, 14:623-634.
43. O'Brien L.C., Keeney P.M., Bennett J.P. Differentiation of human neural stem cells into motor neurons stimulates mitochondrial biogenesis and decreases glycolytic flux. Stem Cells Dev. 2015, 24:1984-1994.
44. Stevens D.A., Lee Y., Kang H.C., Lee B.D., Lee Y.I., Bower A., Jiang H., Kang S.U., Andrabi S.A., Dawson V.L., Shin J.H.O., Dawson T.M. Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:1701-11696.
45. Shaltouki A., Sivapatham R., Pei Y., Gerencser A.A., Momčilović O., Rao M.S., Zeng X. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Rep. 2015, 4:847-859.
46. Goh L.H., Zhou X., Lee M.C., Lin S., Wang H., Luo Y., Yang X. Clueless regulates aPKC activity and promotes self-renewal cell fate in Drosophila lgl mutant larval brains. Dev. Biol. 2013, 381:353-364.
47. Xavier J.M., Morgado A.L., Solá S., Rodrigues C.M. Mitochondrial translocation of p53 modulates neuronal fate by preventing differentiationinduced mitochondrial stress. Antioxid. Redox Signal. 2014, 21:1009-1024.
48. Kulawiec M., Ayyasamy V., Singh K.K. p53 regulates mtDNA copy number and mitocheckpoint pathway. J. Carcinog. 2009, 8.
49. Buechner N., Droese S., Jakob S., Brandt U., Altschmied J., Haendeler J. Mitochondrial TERT enhances mitochondria functions in vivo by protecting mitochondrial DNA integrity from oxidative damage. Cell Commun. Signal. 2009, 7:A57.
50. Estrada J.C., Torres Y., Benguría A., Dopazo A., Roche E., Carrera-Quintanar L., Pérez R.A., Enríquez J.A., Torres R., Ramírez J.C., Samper E., Bernad A. Human mesenchymal stem cellí-replicative senescence and oxidative stress are closely linked to aneuploidy. Cell Death Dis. 2013, 4:e691.
51. Kovalenko O.A., Caron M.J., Ulema P., Medrano C., Thomas A.P., Kimura M., Bonini M.G., Herbig U., Santos J.H. A mutant telomerase defective in nuclear--cytoplasmic shuttling fails to immortalize cells and is associated with mitochondrial dysfunction. Aging Cell 2010, 9:203-219.
52. Rai P., Young J.J., Burton D.G., Giribaldi M.G., Onder T.T., Weinberg R.A. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. Oncogene 2011, 30:1489-1496.
53. Kaplon J., Zheng L., Meissl K., Chaneton B., Selivanov V.A., Mackay G., van der Burg S.H., Verdegaal E.M., Cascante M., Shlomi T., Gottlieb E., Peeper D.S. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013, 498:109-112.
54. Schell J.C., Olson K.A., Jiang L., Hawkins A.J., Van Vranken J.G., Xie J., Egnatchik R.A., Earl E.G., DeBerardinis R.J., Rutter J. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol. Cell 2014, 56:400-413.
55. Ho J.H., Chen Y.F., Ma W.H., Tseng T.C., Chen M.H., Lee O.K. Cell contact accelerates replicative senescence of human mesenchymal stem cells independent of telomere shortening and p53 activation: roles of Ras and oxidative stress. Cell Transplant. 2011, 20:1209-1220.
56. Barger J.L., Walford R.L., Weindruch R. The retardation of aging by caloric restriction: its significance in the transgenic era. Exp. Gerontol. 2003, 38:1343-1351.
57. Cantó C., Auwerx J. Calorie restriction: is AMPK a key sensor and effector?. Physiology (Bethesda) 2011, 26:214-224.
58. Cantó C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., Elliott P.J., Puigserver P., Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
59. Cerletti M., Jang Y.C., Finley L.W.S., Haigis M.C., Wagers A.J. Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 2012, 10:515-519.
60. Chen J., Astle C.M., Harrison D.E. Hematopoietic senescence is postponed and hematopoietic stem cell function is enhanced by dietary restriction. Exp. Hematol. 2003, 31:1097-1103.
61. Miyamoto K., Araki K.Y., Naka K., Arai F., Takubo K., Yamazaki S., Matsuoka S., Miyamoto T., Ito K., Ohmura M., Chen C., Hosokawa K., Nakauchi H., Nakayama K., Nakayama K.I., Harada M., Motoyama N., Suda T., Hirao A. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007, 1:101-112.
62. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., McDowell E.P., Lazo-Kallanian S., Williams I.R., Sears C., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128:325-339.
63. Yalcin S., Zhang X., Luciano J.P., Mungamuri S.K., Marinkovic D., Vercherat C., Sarkar A., Grisotto M., Taneja R., Ghaffari S. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J. Biol. Chem. 2008, 283:2705-25692.
64. -/- mice. EMBO J. 2010, 29:4118-4131.
65. Warr M.R., Binnewies M., Flach J., Reynaud D., Garg T., Malhotra R., Debnath J., Passegué E. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 2013, 494:323-327.
66. Rimmelé P., Liang R., Bigarella C.L., Kocabas F., Xie J., Serasinghe M.N., Chipuk J., Sadek H., Zhang C.C., Ghaffari S. Mitochondrial metabolism in hematopoietic stem cells requires functional FOXO3. EMBO Rep. 2015, 16:1164-1176.
67. Drummond-Barbosa D., Spradling A.C. Stem cells and their progeny respond to nutritional changes during Drosophila oogenesis. Dev. Biol. 2001, 231:265-278.
68. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277:942-946.
69. LaFever L., Drummond-Barbosa D. Direct control of germline stem cell division and cyst growth by neural insulin in Drosophila. Science 2005, 309:1071-1073.
70. Hsu H.-J., LaFever L., Drummond-Barbosa D. Diet controls normal and tumorous germline stem cells via insulin-dependent and -independent mechanisms in Drosophila. Dev. Biol. 2008, 313:700-712.
71. Ueishi S., Shimizu H., H Inoue Y. Male germline stem cell division and spermatocyte growth require insulin signaling in Drosophila. Cell Struct. Funct. 2009, 34:61-69.
72. Wang Z.A., Huang J., Kalderon D. Drosophila follicle stem cells are regulated by proliferation and niche adhesion as well as mitochondria and ROS. Nat. Commun. 2012, 3:769.
73. Egan D.F., Shackelford D.B., Mihaylova M.M., Gelino S., Kohnz R.A., Mair W., Vasquez D.S., Joshi A., Gwinn D.M., Taylor R., Asara J.M., Fitzpatrick J., Dillin A., Viollet B., Kundu M., Hansen M., Shaw R.J. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331:456-461.
74. Schieke S.M., et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 2006, 281:627-643.
75. Cunningham J.T., et al. mTOR controls mitochondrial oxidative function through a YY1-PGC-1α riptional complex. Nature 2007, 450:736-740.
76. Ramanathan A., Schreiber S.L. Direct control of mitochondrial function by mTOR. Proc. Natl Acad. Sci. U. S. A. 2009, 106:22229-22232.
77. Chen C., Liu Y., Liu R., Ikenoue T., Guan K.L., Liu Y., Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 2008, 205:2397-2408.
78. Chen C., Liu Y., Liu Y., Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal. 2009, 2:ra75.
79. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., Nadon N.L., Wilkinson J.E., Frenkel K., Carter C.S., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
80. Shim J., Mukherjee T., Banerjee U. Direct sensing of systemic and nutritional signals by haematopoietic progenitors in Drosophila. Nat. Cell Biol. 2012, 14:394-400.
81. Castilho R.M., Squarize C.H., Chodosh L.A., Williams B.O., Gutkind J.S. mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 2009, 5:279-289.
82. Yilmaz O.H., Katajisto P., Lamming D.W., Gültekin Y., Bauer-Rowe K.E., Sengupta S., Birsoy K., Dursun A., Yilmaz V.O., Selig M., et al. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 2012, 486:490-495.
83. Gan B., Hu J., Jiang S., Liu Y., Sahin E., Zhuang L., Fletcher-Sananikone E., Colla S., Wang Y.A., Chin L., et al. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 2010, 468:701-704.
84. Gurumurthy S., Xie S.Z., Alagesan B., Kim J., Yusuf R.Z., Saez B., Tzatsos A., Ozsolak F., Milos P., Ferrari F., et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 2010, 468:659-663.
85. Nakada D., Saunders T.L., Morrison S.J. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 2010, 468:653-658.
86. Dasgupta B., Milbrandt J. AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev. Cell 2009, 16:256-270.
87. Narbonne P., Roy R. Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling. Development 2006, 133:611-619.
88. Harman D. A biologic clock: the mitochondria?. J. Am. Geriatr. Soc. 1972, 20(4):145-147.
89. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., Bohlooly Y.M., Gidlof S., Oldfors A., Wibom R., Tornell J., Jacobs H.T., Larsson N.G. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429:417-423.
90. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484.
91. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
92. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447:725-729.
93. Chen M.L., Logan T.D., Hochberg M.L., Shelat S.G., Yu X., Wilding G.E., Tan W., Kujoth G.C., Prolla T.A., Selak M.A., Kundu M., Carroll M., Thompson J.E. Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood 2009, 114:4045-4053.
94. Norddahl G.L., Pronk C.J., Wahlestedt M., Sten G., Nygren J.M., Ugale A., Sigvardsson M., Bryder D. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 2011, 8:499-510.
95. Ahlqvist K.J., Hamalainen R.H., Yatsuga S., Uutela M., Terzioglu M., Gotz A., Forsstrom S., Salven P., Angers-Loustau A., Kopra O.H., Tyynismaa H., Larsson N.G., Wartiovaara K., Prolla T., Trifunovic A., Suomalainen A. Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab. 2012, 15:100-109.
96. Fox R.G., Magness S., Kujoth G.C., Prolla T.A., Maeda N. Mitochondrial DNA polymerase editing mutation, PolgD257A, disturbs stem-progenitor cell cycling in the small intestine and restricts excess fat absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G914-G924.
97. Wulfert M., Kupper A.C., Tapprich C., Bottomley S.S., Bowen D., Germing U., Haas R., Gattermann N. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes. Exp. Hematol. 2008, 36:577-586.
98. Yao Y.G., Kajigaya S., Feng X., Samsel L., McCoy J.P., Torelli G., Young N.S. Accumulation of mtDNA variations in human single CD34 + cells from maternally related individuals: effects of aging and family genetic background. Stem Cell Res. 2013, 10:361-370.
99. Baines H.L., Stewart J.B., Stamp C., Zupanic A., Kirkwood T.B., Larsson N.G., Turnbull D.M., Greaves L.C. Similar patterns of clonally expanded somatic mtDNA mutations in the colon of heterozygous mtDNA mutator mice and ageing humans. Mech. Ageing Dev. 2014, 139:22-30.
100. Deng W., Aimone J.B., Gage F.H. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?. Nat. Rev. Neurosci. 2010, 11:339-350.
101. Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 1996, 16:2027-2033.
102. Kukreja L., Kujoth G.C., Prolla T.A., Van Leuven F., Vassar R. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease. Mol. Neurodegener. 2014, 9:16.
103. Hämäläinen R.H., Ahlqvist K.J., Ellonen P., Lepistö M., Logan A., Otonkoski T., Murphy M.P., Suomalainen A. mtDNA mutagenesis disrupts pluripotent stem cell function by altering redox signaling. Cell Rep. 2015, 11:1-11.
104. Dai D.F., Chen T., Wanagat J., Laflamme M., Marcinek D.J., Emond M.J., Ngo C.P., Prolla T.A., Rabinovitch P.S. Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 2010, 9:536-544.
105. Logan A., Shabalina I.G., Prime T.A., Rogatti S., Kalinovich A.V., Hartley R.C., Budd R.C., Cannon B., Murphy M.P. In vivo levels of mitochondrial hydrogen peroxide increase with age in mtDNA mutator mice. Aging Cell 2014, 13:765-768.
106. Dillon L.M., Williams S.L., Hida A., Peacock J.D., Prolla T.A., Lincoln J., Moraes C.T. Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. Hum. Mol. Genet. 2012, 21:2288-2297.
107. Katajisto P., Döhla J., Chaffer C.L., Pentinmikko N., Marjanovic N., Iqbal S., Zoncu R., Chen W., Weinberg R.A., Sabatini D.M. Stem cells: asymmetric apportioning of aged mitochondria between daughter cells is required for stemness. Science 2015, 348:340-343.
108. Dimas A.S., Lagou V., Barker A., Knowles J.W., Mägi R., Hivert M.F., Benazzo A., Rybin D., Jackson A.U., Stringham H.M., Song C., et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 2014, 63:2158-2171.
109. Simoneau J.A., Kelley D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 1997, 83:166-171.
110. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
111. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005, 54:8-14.
112. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
113. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8466-8471.
114. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
115. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350:664-671.
116. Petersen K.F., Dufour S., Shulman G.I. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med. 2005, 2:e233.
117. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6:389-402.
118. van den Ouweland J.M., Lemkes H.H., Ruitenbeek W., Sandkuijl L.A., de Vijlder M.F., Struyvenberg P.A., van de Kamp J.J., Maassen J.A. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1992, 1:368-371.
119. Wilson F.H., Hariri A., Farhi A., Zhao H., Petersen K.F., Toka H.R., Nelson-Williams C., Raja K.M., Kashgarian M., Shulman G.I., Scheinman S.J., Lifton R.P. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004, 306:1190-1194.
120. Yoshida R., Ishida Y., Abo K., Hozumi T., Ueno H., Shiotani H., Kishimoto-Hashiramoto M., Hashiramoto M., Matsunaga K., Kasuga M., et al. Hypertrophic cardiomyopathy in patients with diabetes mellitus associated with mitochondrial tRNA(Leu)(UUR) gene mutation. Intern. Med. 1995, 34:953-958.
121. Akita Y., Koga Y., Iwanaga R., Wada N., Tsubone J., Fukuda S., Nakamura Y., Kato H. Fatal hypertrophic cardiomyopathy associated with an A8296G mutation in the mitochondrial tRNA(Lys) gene. Hum. Mutat. 2000, 15:382.
122. Alila O.F., Rebai E.M., Tabebi M., Tej A., Chamkha I., Tlili A., Bouguila J., Tilouche S., Soyah N., Boughamoura L., Fakhfakh F. Whole mitochondrial genome analysis in two families with dilated mitochondrial cardiomyopathy: detection of mutations in MT-ND2 and MT-TL1 genes. Mitochondrial DNA 2015, 10:1-8.
123. Brisca G., Fiorillo C., Nesti C., Trucco F., Derchi M., Andaloro A., Assereto S., Morcaldi G., Pedemonte M., Minetti C., Santorelli F.M., Bruno C. Early onset cardiomyopathy associated with the mitochondrial tRNALeu((UUR)) 3271T > C MELAS mutation. Biochem. Biophys. Res. Commun. 2015, 456:601-604.
124. Mohlke K.L., Jackson A.U., Scott L.J., Peck E.C., Suh Y.D., Chines P.S., Watanabe R.M., Buchanan T.A., Conneely K.N., Erdos M.R., Narisu N., Enloe S., Valle T.T., Tuomilehto J., Bergman R.N., Boehnke M., Collins F.S. Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Hum. Genet. 2005, 118:245-254.
125. Crispim D., Canani L.H., Gross J.L., Tschiedel B., Souto K.E.P., Roisenberg I. The European-specific mitochondrial cluster J/T could confer an increased risk of insulin-resistance and type 2 diabetes: an analysis of the m.4216TNC and m.4917ANG variants. Ann. Hum. Genet. 2006, 70:488-495.
126. Fuku N., Park K.S., Yamada Y., Nishigaki Y., Cho Y.M., Matsuo H., Segawa T., Watanabe S., Kato K., Yokoi K., Nozawa Y., Lee H.K., Tanaka M. Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am. J. Hum. Genet. 2007, 80:407-415.
127. Liou C.-W., Chen J.-B., Tiao M.-M., Weng S.-W., Huang T.-L., Chuang J.-H., Chen S.-D., Chuang Y.-C., Lee W.-C., Lin T.-K., Wang P.-W. Mitochondrial DNA coding and control region variants as genetic risk factors for type 2 diabetes. Diabetes 2012, 61:2642-2651.
128. Kofler B., Mueller E.E., Eder W., Stanger O., Maier R., Weger M., Haas A., Winker R., Schmut O., Paulweber B., Iglseder B., Renner W., Wiesbauer M., Aigner I., Santic D., Zimmermann F.A., Mayr J.A., Sperl W. Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study. BMC Med. Genet. 2009, 10:35.
129. Achilli A., Olivieri A., Pala M., Kashani B.H., Carossa V., Perego U.A., Gandini F., Santoro A., Battaglia V., Grugni V., Lancioni H., Sirolla C., Bonfigli A.R., Cormio A., Boemi M., Testa I., Semino O., Ceriello A., Spazzafumo L., Gadaleta M.N., Marra M., Testa R., Franceschi C., Torroni A. Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PLoS One 2011, 6:e21029.
130. Strauss K.A., DuBiner L., Simon M., Zaragoza M., Sengupta P.P., Li P., Narula N., Dreike S., Platt J., Procaccio V., Ortiz-González X.R., Puffenberger E.G., Kelley R.I., Morton D.H., Narula J., Wallace D.C. Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3453-3458.
131. Hwang S., Kwak S.H., Bhak J., Kang H.S., Lee Y.R., Koo B.K., Park K.S., Lee H.K., Cho Y.M. Gene expression pattern in transmitochondrial cytoplasmic hybrid cells harboring type 2 diabetes-associated mitochondrial DNA haplogroups. PLoS One 2011, 6:e22116.
132. Sosa-Ortiz A.L., Acosta-Castillo I., Prince M.J. Epidemiology of dementias and Alzheimer's disease. Arch. Med. Res. 2012, 43:600-608.
133. Chinnery P.F., Hudson G. Mitochondrial genetics. Br. Med. Bull. 2013, 106:135-159.
134. Santoro A., Balbi V., Balducci E., Pirazzini C., Rosini F., Tavano F., Achilli A., Siviero P., Minicuci N., Bellavista E., Mishto M., Salvioli S., Marchegiani F., Cardelli M., Olivieri F., Nacmias B., Chiamenti A.M., Benussi L., Ghidoni R., Rose G., Gabelli C., Binetti G., Sorbi S., Crepaldi G., Passarino G., Torroni A., Franceschi C. Evidence for sub-haplogroup H5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS One 2010, 5:e12037.
135. Coto E., Gómez J., Alonso B., Corao A.I., Díaz M., Menéndez M., Martínez C., Calatayud M.T., Morís G., Álvarez V. Late-onset Alzheimer's disease is associated with mitochondrial DNA 7028C/haplogroup H and D310 poly-C tract heteroplasmy. Neurogenetics 2011, 12:345-346.
136. Carrieri G., Bonafè M., De Luca M., Rose G., Varcasia O., Bruni A., Maletta R., Nacmias B., Sorbi S., Corsonello F., Feraco E., Andreev K.F., Yashin A.I., Franceschi C., DeBenedictis G. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum. Genet. 2001, 108:194-198.
137. Chagnon P., Gee M., Filion M., Robitaille Y., Belouchi M., Gauvreau D. Phylogenetic analysis of themitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am. J. Med. Genet. 1999, 85:20-30.
138. Fesahat F., Houshmand M., Panahi M.S.S., Gharagozli K., Mirzajani F. Do haplogroups H and U act to increase the penetrance of Alzheimer's disease?. Cell. Mol. Neurobiol. 2007, 27:329-334.
139. Lakatos A., Derbeneva O., Younes D., Keator D., Bakken T., Lvova M., Brandon M., Guffanti G., Reglodi D., Saykin A., Weiner M., Macciardi F., Schork N., Wallace D.C., Potkin S.G. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol. Aging 2010, 31:1355-1363.
140. Maruszak A., Canter J.A., Styczyńska M., Zekanowski C., Barcikowska M. Mitochondrial haplogroup H and Alzheimer's disease-is there a connection?. Neurobiol. Aging 2009, 30:1749-1755.
141. Van Der Walt J.M., Dementieva Y.A., Martin E.R., Scott W.K., Nicodemus K.K., Kroner C.C., Welsh-Bohmer K.A., Saunders A.M., Roses A.D., Small G.W., Schmechel D.E., Murali Doraiswamy P., Gilbert J.R., Haines J.L., Vance J.M., Pericak-Vance M.A. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci. Lett. 2004, 365:28-32.
142. Reddy P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp. Neurol. 2009, 218:286-292.
143. Krishnan K.J., Ratnaike T.E., De Gruyter H.L.M., Jaros E., Turnbull D.M. Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease. Neurobiol. Aging 2012, 33:2210-2214.
144. Yan M.H., Wang X., Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med. 2013, 62:90-101.
145. Cha M.-Y., Han S.-H., Son S.M., Hong H.-S., Choi Y.-J., Byun J., et al. Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 2012, 7:e34929.
146. Van der Walt J.M., Nicodemus K.K., Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Haines J.L., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H., Goetz C.G., Small G.W., Mastaglia F., Stajich J.M., McLaurin A.C., Middleton L.T., Scott B.L., Schmechel D.E., Pericak-Vance M.A., Vance J.M. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 2003, 72:804-811.
147. Kraytsberg Y., Kudryavtseva E., McKee A.C., Geula C., Kowall N.W., Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 2006, 38:518-520.
148. Winklhofer K.F., Haass C. Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 2010, 1802:29-44.
149. Jin H., Kanthasamy A., Ghosh A., Anantharam V., Kalyanaraman B., Kanthasamy A.G. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochim. Biophys. Acta 2013, 1842:1282-1294.
150. Pickrell A.M., Pinto M., Hida A., Moraes C.T. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease. J. Neurosci. 2011, 31:17649-17658.
151. Tufi R., Gandhi S., de Castro I.P., Lehmann S., Angelova P.R., Dinsdale D., et al. Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease. Nat. Cell Biol. 2014, 16:157-166.
152. Liu W., Acín-Peréz R., Geghman K.D., Manfredi G., Lu B., Li C. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:12920-12924.